Search results for "HPV"
Cost-effectiveness of HPV vaccination after age 26 low, varies by risk factors
A model found that human papillomavirus (HPV) vaccination of men and women ages 27 to 45 years cost $2,005,000 per quality-adjusted life-year gained. Vaccinating patients in this age range who had more partners or had recently left a relationship was more cost-effective.
https://immattersacp.org/weekly/archives/2024/12/03/1.htm
3 Dec 2024
Raising awareness about HPV-related cancers
The human papillomavirus (HPV) vaccine can potentially prevent more than 90% of HPV-associated cancers. Generally given to teens, it can be offered to adults as well.
https://immattersacp.org/archives/2023/10/raising-awareness-about-hpv-related-cancers.htm
1 Oct 2023
Home-based HPV screening appears cost-effective, study finds
In an economic evaluation of 19,851 female participants from a randomized clinical trial, incremental cost-effectiveness ratios for increased uptake of human papillomavirus (HPV) screening ranged from $86 to $146 per additional screening completed.
https://immattersacp.org/weekly/archives/2023/03/28/4.htm
28 Mar 2023
HPV vaccine impacts disease, screening
While HPV immunization is recommended during adolescence, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
https://immattersacp.org/archives/2017/02/hpv.htm
1 Feb 2017
Decrease in certain HPV types among unvaccinated women suggests herd protection
Prevalence of the four types of human papillomavirus (HPV) included in the original vaccine decreased most among women who were fully vaccinated but also decreased significantly among women who were unvaccinated between 2006 and 2017.
https://immattersacp.org/weekly/archives/2019/01/29/4.htm
29 Jan 2019
HPV vaccine efficacy increases, but use lags
Human papillomavirus immunization rates continue, for several reasons, to lag behind those of other vaccines. Experts are formulating new approaches for physicians and patients to ensure that HPV protection is as robust as possible.
https://immattersacp.org/archives/2016/02/HPV.htm
1 Feb 2016
HPV testing compared with cytology may result in less cervical intraepithelial neoplasia
Clinicians will have to choose between primary human papillomavirus testing and co-testing based on modeling and cost-effectiveness studies, an editorial noted.
https://immattersacp.org/weekly/archives/2018/07/10/2.htm
10 Jul 2018
Little health benefit, higher costs likely with extended age limit for HPV vaccination
A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
https://immattersacp.org/weekly/archives/2019/12/10/1.htm
10 Dec 2019
Troubleshooting tips for cervical cancer screening
Two experts advise physicians on cervical cancer screening, dealing with issues from sampling technique to confusing guidelines.
https://immattersacp.org/archives/2024/07/troubleshooting-tips-for-cervical-cancer-screening.htm
1 Jul 2024
HPV vaccination now impacts practice later
This issue covers such topics as HPV vaccination, news from ObesityWeek, and a preview of upcoming events at Internal Medicine Meeting 2017.
https://immattersacp.org/archives/2017/02/editors.htm
1 Feb 2017